CVRx Reports Q3 Revenue of $13.8 Million, Updates 2026 Guidance
CVRx reported third-quarter revenue of $13.8 million, including $13.0 million in U.S. revenue. It raised its full-year 2026 revenue guidance to $56 million–$57 million.
CVRx, Inc. reported total revenue of $13.8 million for the third quarter of 2026, with U.S. revenue accounting for $13.0 million. The company noted that active implanting centers in the U.S.
grew to 262 as of September 30, 2026, compared to 250 in the prior year. Additionally, the company announced the appointment of John Landry as Chief Financial Officer, effective November 6, 2026. Management highlighted progress in expanding Medicare Advantage coverage and clinical evidence development. For the full year 2026, the company updated its total revenue guidance to a range of $56.0 million to $57.0 million.